Journal profile · IMMUNOLOGY

Journal of Inflammation-London

ISSN 1476-9255 · BioMed Central · ENGLAND · Irregular · Founded 2004

Journal of Inflammation-London: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 5.86; fully open access; APC about USD 3,290; median 125 days to acceptance (91 articles, last 24 months); community-reported acceptance: fairly easy; 57 articles in 2025; indexed in SCIE and Scopus.

Impact factor5.86Latest value listed by LetPub
CAS zoneZone 3 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 2 · Medicine
Review time125 daysMedian, submission to acceptance · 91 articles, last 24 months · Crossref
APCUSD 3,290Fully open access
AcceptanceFairly easyCommunity average
Articles per year572025 · OpenAlex count

Scope

Aims, scope and focus

Journal of Inflammation-London is published by BioMed Central and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Immune Response and Inflammation, Asthma and respiratory diseases and Immune cells in cancer, together about 31.3% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)

Journal of Inflammation welcomes research submissions on all aspects of inflammation. The five classical symptoms of inflammation, namely redness (rubor), swelling (tumour), heat (calor), pain (dolor) and loss of function (functio laesa), are only part of the story. The term inflammation is taken to include the full range of underlying cellular and molecular mechanisms involved, not only in the initiation and propagation of inflammation in order to defend against infection, but also in the resolution of inflammation and associated repair processes. Thus the journal covers molecular, cellular, animal and clinical studies, and related aspects of pharmacology, such as anti-inflammatory drug development, trials and therapeutic developments. It also considers publication of negative findings. Journal of Inflammation aims to become the leading online journal on inflammation and, as online journals replace printed ones over the next decade, the main open access inflammation journal. Open access guarantees a larger audience, and thus impact, than any restricted access equivalent, and increasingly so, as the escalating costs of printed journals puts them outside University budgets. The unrestricted access to research findings in inflammation aids in promoting dynamic and productive dialogue between industrial and academic members of the inflammation research community, which plays such an important part in the development of future generations of anti-inflammatory therapies.

From the journal's Aims & Scope

Research area (LetPub): IMMUNOLOGY

Editor-in-chief Paul KirkhamPublisher website

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Immune Response and InflammationImmunology and Microbiology14.9%
  2. Asthma and respiratory diseasesMedicine9.4%
  3. Immune cells in cancerImmunology and Microbiology7.1%
  4. Neutrophil, Myeloperoxidase and Oxidative MechanismsImmunology and Microbiology6.3%
  5. Adipokines, Inflammation, and Metabolic DiseasesMedicine6.1%
  6. Inflammasome and immune disordersBiochemistry, Genetics and Molecular Biology5.7%
  7. Cell Adhesion Molecules ResearchMedicine3.7%
  8. Chronic Obstructive Pulmonary Disease (COPD) ResearchMedicine3.5%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
LevelCategoryZone
MajorMedicineZone 3
MinorImmunologyZone 3

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
LevelCategoryZone
MajorMedicineZone 2
MinorImmunologyZone 3

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
LevelCategoryZone
MajorMedicineZone 3
MinorImmunologyZone 3

Top journal: noReview journal: no

Database indexing

SCIEScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

EmbaseCASCAB AbstractsPublisher website

Other: Google Scholar, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
5.86LetPub ·
Impact factor (publisher) 2025
5.8Publisher website ·
5-year impact factor (publisher) 2025
5.1Publisher website ·
CiteScore 2026-06
6.8LetPub ·
SJR 2026-06
1.32LetPub ·
SNIP 2026-06
1.03LetPub ·
h-index
45LetPub ·
h-index
83OpenAlex ·
i10-index
590OpenAlex ·
2-year mean citedness
5.31OpenAlex ·
Self-citation rate
0%LetPub ·
Share of gold OA articles
100%LetPub ·

Volume

Articles per year
52LetPub ·
Downloads per year (publisher) 2025
611,900Publisher website ·

Articles by year OpenAlex count · 877 in total · the current year is incomplete

YearArticlesOpen accessCitations
2026313113
20255757253
20245454488
20234646846
20222828512
20213131885

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with Crossref · to

125 daysMedian, submission to acceptance · P25–P75 89 days – 209 days

Acceptance to online
median 17 days (91 articles)
Submission to online
median 163 days
Sample
91 articles with submission and acceptance dates (105 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
over 12 weeksLetPub ·
Average acceptance (community reports)
Fairly easyLetPub ·
Submission to first decision
15 daysPublisher website ·
Submission to publication (journal-reported)
about 27 weeksDOAJ ·
Peer review
Single anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessDOAJ

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
DOAJGBP 2,390 / USD 3,290 / EUR 2,790YesCC BY, CC BY-NC-ND
OpenAlexUSD 3,190 / EUR 2,690 / GBP 2,290——
LetPubGBP 2,390 / USD 3,290 / EUR 2,790Yes—
Publisher websiteGBP 2,390 / USD 3,290 / EUR 2,790——

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

Open calls for papers1, by deadline
  1. Sex Differences in InflammationDeadline
Publisher website
What to prepare3 items from the author guidelines
Reference style
Vancouver
Templates
LaTeX and Word
Suggested reviewers
Optional
Publisher website · model-extracted, each line checked against the text
Article types accepted3
  1. brief reportFormatting guidelines for specific article types can be found below. Research Reviews Brief ReportLength not stated
  2. researchFormatting guidelines for specific article types can be found below. Research Reviews Brief ReportLength not stated
  3. reviewsFormatting guidelines for specific article types can be found below. Research Reviews Brief ReportLength not stated
Publisher website
Policy excerpts from the journal's websiteData availability, License & copyright, Open access, Peer review
Data availability Formatting the 'Availability of data and materials' section of your manuscript

The following format for the 'Availability of data and materials section of your manuscript should be used:

Source ↗Publisher website ·
License & copyright Licensing and copyright

Open access under CC BY-NC-ND or CC BY licence; authors retain copyright. Model summary

Creative Commons licences Open access articles in Springer Nature journals are published under Creative Commons licences. These provide an industry-standard framework to support easy re-use of open access material. Under Creative Commons licences, authors retain copyright of their articles. Journal of Inflammation articles are published open access under a CC BY-NC-ND (Creative Commons Attribution…

Source ↗Publisher website ·
Open access Benefits of open access

Publishing open access (OA) offers a number of benefits, including greater reach and readership for your work: Cited more 1.6x more citations of OA articles than non-OA articles across all subjects Downloaded more 4x more downloads of OA articles than non-OA articles Greater impact 2.5x more Altmetric attention. OA articles attracted 1.9x more news mentions and 1.2x more policy mentions Open acces…

Source ↗Publisher website ·
Peer review Peer review policy

Peer review is the process used to evaluate the quality of a manuscript before publication. Independent researchers in the relevant field assess submitted manuscripts to check their validity and robustness. Their feedback guides editors in making publication decisions. Typically, two or more experts evaluate each manuscript based on three main criteria: scientific robustness: is the research metho…

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
BioMed Central
Country or region
ENGLAND
Language
English
Frequency
Irregular
Founded
2004
ISSN
1476-9255
Official links

FAQ

Frequently asked questions about Journal of Inflammation-London

What CAS zone is Journal of Inflammation-London in?

In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Inflammation-London is in Zone 3 of Medicine, and in Zone 3 of the minor category Immunology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Journal of Inflammation-London?

The latest impact factor listed by LetPub is 5.86; CiteScore 6.8, h-index 83.

How long does peer review take at Journal of Inflammation-London?

Based on the dates recorded on 91 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 125 days (interquartile range 89–209 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

What are the manuscript requirements of Journal of Inflammation-London?

According to the journal's author guidelines: Reference style: Vancouver; Templates: LaTeX and Word; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.

Which databases index Journal of Inflammation-London?

According to LetPub and DOAJ records, Journal of Inflammation-London is indexed in SCIE, Scopus and DOAJ. The journal's website also lists Embase, CAS and CAB Abstracts; that list has not been checked against each database.

Is Journal of Inflammation-London open access, and what is the APC?

Journal of Inflammation-London is a fully open-access journal. APC about USD 3,290.

Sources and updates

The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .